300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Travel
Platforms
InsurTech
Enterprise Software
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Canada
United Kingdom
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Keio Innovation Initiative, VC Fund

Keio Innovation Initiative

VC Fund

Tokyo, Japan

Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.

Total investments:
90
Last investment:
Lead investor:
30%
Fund size:
$1.4B
Last fund:

Last updated:

Industries Keio Innovation Initiative invests in

Health CareMedicalBiotechnologyManufacturingMedical Device

Stages Keio Innovation Initiative invests in

Series ASeedFunding RoundSeries BVenture - Series Unknown

Countries Keio Innovation Initiative invests in

JapanUnited Kingdom

Round sizes

Seed $826k–$50MSeries A $2.2M–$64M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

2 more contacts available

Round size

Seed
$826k–$50M
Series A
$2.2M–$64M

Investment Focus

Industry

  • Health Care 15 (17%)
  • Medical 14 (16%)
  • Biotechnology 14 (16%)
  • Manufacturing 8 (9%)
  • Medical Device 8 (9%)
See all 100 industries →

Stage

  • Series A 22 (24%)
  • Seed 19 (21%)
  • Funding Round 13 (14%)
  • Series B 9 (10%)
  • Venture - Series Unknown 7 (8%)
See all 11 stages →

Country

  • Japan 60 (67%)
  • United Kingdom 1 (1%)

Team

NameTitleInvestmentsLinksEmail
Kotaro Yamagishi
Kotaro Yamagishi Founder & CEO
Founder & CEO Total investments: 4
Find email
Shuichi Kinoshita
Shuichi Kinoshita corporate officer
corporate officer Total investments: 2
Find email
Yusuke Satake
Yusuke Satake Principal
Principal Total investments: 4
Find email

Investments

CompanyDescriptionRoundLinks
Starlight Engine Starlight Engine
Starlight Engine develops and commercializes fusion energy power plant technologies. $37.4M / Seed / Jul 15, 2026
Neusignal Therapeutics Neusignal Therapeutics
Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses. $32.8M / Series B / Jun 30, 2026
Neusignal Therapeutics Neusignal Therapeutics
Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses. $32.8M / Series B / Jun 30, 2026
JiMED JiMED
JiMED designs & develops AI based brain-computer interface for implant in ALS patients to improve communication. $2M / Jun 18, 2026
Grafenary Grafenary
Graphenary creates unique graphene optical devices using graphene materials with a variety of remarkable features. $1.5M / Seed / Apr 27, 2026
Orbital Lasers Orbital Lasers
Orbital is a space tech company that provides space debris business to remove debris and a satellite LiDAR business to provide surface data. $19.2M / Series A / Mar 19, 2026
Eco-Pork Eco-Pork
Eco-Pork is a co-creation solution farm that supports farmers' food productivity improvement. It is connecting the pig and technology, pork ( Pork ) new business ecosystems ( Ecosystem By building a), in the pork growing demand around the world, to get the most out of the food supply capacity is finite. $9M / Venture - Series Unknown / Nov 28, 2025
Surv Biopharma Surv Biopharma
Surv Biopharma develops a drug discovery platform that facilitates research and development of veterinary drugs and pharmaceutical products. $14.1M / Series B / Nov 11, 2025
Space quarters Space quarters
Space Quarters is a manufacturing company that produces payload deploy and panels, and develops space assembly robotic systems. $5M / Seed / Oct 15, 2025
Z-Works Z-Works
"Z-Works Life Engine" is a cloud-type IoT platform. Collect and analyze the data of the terminal equipped with Z-Wave on the cloud, you can browse various data with the smartphone and remotely control the terminal equipped with Z-Wave. $4.7M / Oct 06, 2025
See all 90 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Travel
Platforms
InsurTech
Enterprise Software
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Paraguay
Seychelles
Botswana
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Canada
United Kingdom
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Keio Innovation Initiative invest in?

Keio Innovation Initiative invests primarily in Health Care, Medical and Biotechnology startups, most often at Series A and Seed stage. Most of the 90 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Keio Innovation Initiative's check size?

Keio Innovation Initiative typically joins rounds of $826k–$50M at Seed and $2.2M–$64M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Keio Innovation Initiative participates in.

How do I contact Keio Innovation Initiative?

Public channels for Keio Innovation Initiative include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Keio Innovation Initiative?

The team at Keio Innovation Initiative includes Kotaro Yamagishi (Founder & CEO), Shuichi Kinoshita (corporate officer) and Yusuke Satake (Principal). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Keio Innovation Initiative Keio Innovation Initiative Find emails